Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00863694 · ClinicalTrials.gov registry record
Fecal Calprotectin in Cystic Fibrosis
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 106
- Enrollment target
NCT00863694: Completed study, sponsored by Medical College of Wisconsin.
NCT00863694 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00863694 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
Elevated fecal calprotectin is a biomarker for intestinal inflammation in cystic fibrosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2009-02 |
| Est. Completion | 2013-08 |
What the finished NCT00863694 record still lists
NCT00863694 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00863694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00863694 about?
NCT00863694 is a clinical study titled "Fecal Calprotectin in Cystic Fibrosis". Elevated fecal calprotectin is a biomarker for intestinal inflammation in cystic fibrosis
What is the current status of trial NCT00863694?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2009-02. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT00863694?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia